Research Paper Volume 15, Issue 24 pp 15473—15488

Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study

class="figure-viewer-img"

Figure 1. Flow diagram of selecting patients.